Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-05
2006-09-05
Tsang, Cecilia (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S115000, C562S490000, C514S187000, C514S481000
Reexamination Certificate
active
07102008
ABSTRACT:
The present invention provides compounds of Formula (I):or a stereoisomer or pharmaceutically acceptable salt form thereof, wherein the variables A, R1, R2, R3, R4, Z, U, X, Y, Za, and n are defined are as defined herein, which are useful as inhibitors of matrix metalloproteinases (MMP) and/or TNF-α converting enzyme (TACE), or a combination thereof.
REFERENCES:
patent: 4769461 (1988-09-01), Musser et al.
patent: 5358955 (1994-10-01), Brooks et al.
patent: H1992 (2001-09-01), Bender et al.
patent: 10-875667 (1998-04-01), None
patent: WO 98/05635 (1998-02-01), None
patent: WO 01/36365 (2001-05-01), None
Daheshia, M., Therapeutic inhibition of matrix metalloproteinases for the treatment of chronic obstructive pulmonary disease (COPD), Current Medical Research and Opinion, vol. 21, No. 4, 2005, 587-593.
Levin, Jl., “The design and synthesis of aryl hydroxamide acid inhibitors of MMPs and TACE”, Curr. Top. Med. Chem., 2004; 4(12)—abstract.
Mannello, et. al., “Matrix metalloproteinase inhibitors as anticancer therapeutics”, Curr. Cancer Drug Targets, Jun. 2005; 5(4), abstract.
Lukacova, et al., “A Comparison of the Binding Sites of Matrix Metalloproteinases and Tumor Necrosis Factor Converting Enzyme: Implications for Selectivity”, J. Med. Chem., 2005, 48, 2361-2370.
Mackay, et al., “Advances in Immunology”, The New England Journal of Medicine, vol. 345, No. 5, Aug. 2, 2001, pp. 340-350.
Balls James
Bristol--Myers Squibb Company
Sun Jing G.
Tsang Cecilia
LandOfFree
Hydantoin derivatives as inhibitors of matrix... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydantoin derivatives as inhibitors of matrix..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydantoin derivatives as inhibitors of matrix... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3572142